Autoantigens are self-derived molecules that become recognized by the adaptive immune system after tolerance is lost. They may be intracellular enzymes, nuclear ribonucleoproteins, membrane receptors, structural matrix proteins, microbial-response proteins, or tissue-restricted differentiation antigens. In autoimmune and immune-mediated diseases, the target profile is not simply a diagnostic label; it reflects the tissue compartment exposed to inflammation, the route of antigen presentation, the immunoglobulin class or subclass involved, and the effector mechanisms that translate autoantibody binding into tissue injury. For reagent development, assay design, and mechanistic research, each autoantigen should therefore be considered in relation to its native localization, conformational state, post-translational modification, biological function, and disease-associated epitope pattern.
Antiphospholipid syndrome is an autoimmune thrombo-inflammatory condition defined by persistent antiphospholipid antibodies and clinical events such as thrombosis or pregnancy morbidity. The term antiphospholipid is partly historical because the most pathogenic antibodies are usually directed against phospholipid-binding plasma proteins rather than phospholipids alone. The central antigen is beta2-glycoprotein I, a five-domain plasma protein that binds anionic phospholipid surfaces and exposes conformational epitopes when immobilized. Other targets such as prothrombin, phosphatidylserine-prothrombin complexes, annexin V, and protein C pathway components help explain heterogeneity in coagulation activation, complement involvement, endothelial perturbation, and placental injury.
Several recurring mechanisms explain how normally tolerated proteins become immunogenic. Cell stress, apoptosis, necrosis, degranulation, extracellular trap formation, defective clearance of immune complexes, microbial mimicry, and oxidative or enzymatic modification can all increase antigen availability. Once antigen is released or redistributed, antigen-presenting cells process peptides and activate autoreactive T cells. B cells receiving T-cell help undergo clonal expansion, affinity maturation, and class switching, producing antibodies that may serve as biomarkers, pathogenic mediators, or both. The clinical value of an autoantigen depends on antigen quality: recombinant proteins should preserve relevant epitopes, native proteins may retain conformational and post-translational features, and peptide antigens are useful when the dominant epitope is linear and well defined.
Fig. 1 Mechanisms of Immunogenicity in Antiphospholipid Syndrome
The classical and commonly used targets include:
These targets should be selected according to the intended research question, assay platform, desired sensitivity and specificity, sample matrix, and whether the study requires native conformational epitopes, recombinant full-length protein, antigenic domains, or synthetic peptide epitopes.
| Target | Location | Function | Immunological Role |
| Beta2-glycoprotein I (APOH) | Plasma; anionic phospholipid surfaces | Binds phospholipids and modulates coagulation-related surfaces | Major pathogenic and classification-related antigen in APS |
| Cardiolipin-beta2GPI complex | Mitochondrial-derived phospholipid surfaces and assay plates | Provides anionic phospholipid scaffold for beta2GPI binding | Classical anticardiolipin assay antigen system |
| Prothrombin | Plasma and coagulation surfaces | Precursor of thrombin in coagulation cascade | Autoantibody target associated with lupus anticoagulant activity and thrombosis risk |
| Phosphatidylserine-prothrombin complex | Activated/apoptotic cell membranes | Links exposed phosphatidylserine with prothrombin binding | Useful non-criteria target associated with lupus anticoagulant and APS phenotypes |
| Annexin V | Placental trophoblasts and phospholipid membranes | Forms anticoagulant shield over anionic phospholipids | Antibodies may disrupt placental anticoagulant protection |
| Protein C and Protein S pathway antigens | Plasma/endothelial surfaces | Natural anticoagulant regulation | Potential targets contributing to acquired procoagulant tendency |
| Vimentin-cardiolipin complex | Cell surface/cytoskeleton exposed during inflammation | Intermediate filament protein with damage-associated exposure | Emerging target in APS-related inflammatory thrombosis |
Beta2-glycoprotein I changes conformation after binding cardiolipin or phosphatidylserine. Domain I contains important epitopes for clinically relevant antibodies.
Localization and function: Beta2-glycoprotein I (APOH) is primarily associated with plasma; anionic phospholipid surfaces. Its biological role centers on binds phospholipids and modulates coagulation-related surfaces. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Major pathogenic and classification-related antigen in APS. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Cardiolipin itself is not usually the sole antigenic determinant; beta2GPI-dependent binding explains why antigen composition and coating conditions are critical.
Localization and function: Cardiolipin-beta2GPI complex is primarily associated with mitochondrial-derived phospholipid surfaces and assay plates. Its biological role centers on provides anionic phospholipid scaffold for beta2gpi binding. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Classical anticardiolipin assay antigen system. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Anti-prothrombin antibodies may alter coagulation reactions and contribute to phospholipid-dependent clotting assay abnormalities.
Localization and function: Prothrombin is primarily associated with plasma and coagulation surfaces. Its biological role centers on precursor of thrombin in coagulation cascade. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Autoantibody target associated with lupus anticoagulant activity and thrombosis risk. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Anti-PS/PT antibodies recognize a protein-phospholipid complex and often complement beta2GPI-based assays in research panels.
Localization and function: Phosphatidylserine-prothrombin complex is primarily associated with activated/apoptotic cell membranes. Its biological role centers on links exposed phosphatidylserine with prothrombin binding. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Useful non-criteria target associated with lupus anticoagulant and APS phenotypes. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Annexin V binds phosphatidylserine-rich surfaces. Anti-annexin V antibodies have been studied in pregnancy morbidity and trophoblast injury.
Localization and function: Annexin V is primarily associated with placental trophoblasts and phospholipid membranes. Its biological role centers on forms anticoagulant shield over anionic phospholipids. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Antibodies may disrupt placental anticoagulant protection. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Antibodies against regulatory anticoagulant proteins are less standardized but mechanistically relevant for coagulation imbalance.
Localization and function: Protein C and Protein S pathway antigens is primarily associated with plasma/endothelial surfaces. Its biological role centers on natural anticoagulant regulation. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Potential targets contributing to acquired procoagulant tendency. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Vimentin can become surface-exposed on activated cells and may form immunogenic complexes with cardiolipin-like lipids.
Localization and function: Vimentin-cardiolipin complex is primarily associated with cell surface/cytoskeleton exposed during inflammation. Its biological role centers on intermediate filament protein with damage-associated exposure. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Emerging target in APS-related inflammatory thrombosis. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
References
